glp 1 interaction with alcohol GLP-1 receptor agonists for the treatment of use disorder GLP-1 medications: The next big

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says.

Heart failure patients could be the next group to benefit from GLP-1 agonists, which are currently approved for the treatment of diabetes and obesity.

FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products

Does Ozempic give you bad breath

Discover top diabetes weight loss drugs, how they work, and who can benefit